Public Charity

HEMOSTASIS AND THROMBOSIS CENTER OF NEVADA

Based in LAS VEGAS, NV, HEMOSTASIS AND THROMBOSIS CENTER OF NEVADA operates as a Public Charity. The organization reported $29.0M in revenue, $24.4M in expenses, $15.4M in total assets for fiscal year 2025. Imperigo tracks 23 reported grant relationships connected to this organization totaling approximately $603K.

EIN: 822793154 LAS VEGAS, NV Latest filing: 2025
Total Revenue$29.0M
Total Expenses$24.4M
Total Assets$15.4M
Grant Records23
Funding Total$603K
Filing Years2020–2025

Mission

THE PRIMARY PURPOSE OF THE ORGANIZATION IS TO PROVIDE COMPREHENSIVE CLINICAL CARE TO PERSONS AFFECTED BY INHERITED BLOOD DISORDERS AND TO ADMINISTER PROGRAMS SUPPORTED BY FEDERAL GRANTS AWARDED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES HEALTH RESOURCES SERVICES ADMINISTRATION (HRSA) AND BY THE CENTERS OF DISEASE CONTROL (CDC), INCLUDING GRANTS RELATED TO HEMOPHILIA AND SICKLE CELL DISEASE.

Sample Grants Received

2023
SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM
$106,944
2022
SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM
$96,921
2021
SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
$33,575
2021
SUBCONTRACT CDC/ATHN GRANT PUBLIC HEALTH SURVEILLANCE
$31,192
2021
SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM
$28,131

Showing up to 5 of 23 total records — full history available with membership.

Officers & Directors

DIRECTOR OF Alison Bartko
EXECUTIVE DI Craig Foreman
NURSE PRACTI Dwight Generoso
NURSE MANAGE Jeff Nelson
CFO Jerry Fox
SECRETARY Julie Usgaard

Officer compensation and complete director data available with membership.

Top Grant Purposes

SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM
$266,337 4 grants
SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM
$71,360 2 grants
SUBCONTRACT CDC/ATHN GRANT PUBLIC HEALTH SURVEILLANCE
$63,801 2 grants
SUBCONTRACT HRSA GRANT - PUBLIC HEALTH SURVEILLANCE
$55,287 2 grants
SUBCONTRACT HRSA GRANT - HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM
$45,788 2 grants

Financial Trends

Year Revenue Expenses Assets
2025 $29.0M $24.4M $15.4M
2024 $24.1M $23.3M $10.4M
2023 $24.0M $23.2M $9.9M
2021 $21.0M $19.1M $7.5M
2020 $13.7M $12.7M $4.5M

Between 2020 and 2025, reported annual revenue grew from $13.7M to $29.0M (+111%), with total assets most recently reported at $15.4M.

Interactive year-over-year charts and full filing details available with membership.

See the full picture for HEMOSTASIS AND THROMBOSIS CENTER OF NEVADA

Complete financials, all 23 grant records, officer compensation, year-over-year trend charts, a geographic grant map, and data exports — across 498,000+ organizations.

Full Financial History Complete Grant Activity Officer Compensation Year-over-Year Charts Geographic Grant Map Data Exports
7-day free trial Cancel any time